Iatrogenic Calcification
Iatrogenic calcinosis cutis is the abnormal deposition of calcium phosphate crystals in the epidermis, dermis or subcutaneous tissue as a direct complication of a diagnostic test, medical treatment or surgical procedure. It develops even when the patient's blood calcium and phosphate levels are entirely normal, so recognizing the relevant medical history early is essential for planning effective, conservative management.
How It Develops
Depending on the type of medical intervention, iatrogenic calcium deposits form through two main mechanisms:
- Extravasation-induced mechanism:
- When a concentrated calcium solution (such as 10% calcium gluconate or calcium chloride) leaks out of the vein into the surrounding tissue, local calcium and phosphate concentrations suddenly rise above their solubility limit.
- Calcium phosphate crystals then precipitate directly onto the connective tissue and collagen fibers of the dermis.
- Micro-trauma (dystrophic) mechanism:
- Invasive procedures (repeated heel sticks, prolonged electrode placement, local surgery) cause microscopic cell death.
- Dying cells release intracellular calcium, which combines with phosphate from damaged phospholipid membranes and sets the stage for mineral deposition, even though systemic calcium is not raised.
Common Clinical Types
- Calcinosis after calcium extravasation:
- Who is affected: most often premature infants, ICU patients, or patients with acute hypocalcemia who need intravenous calcium.
- Appearance: redness and mild swelling at the infusion site, which after 1–3 weeks turn into firm, whitish to ivory-yellow plaques or nodules, sometimes with superficial epidermal necrosis.
- Electrode-induced calcinosis:
- Who is affected: children or adults who undergo prolonged electroencephalography (EEG) or electrocardiography (ECG).
- Appearance: small, hard round papules or linear streaks located exactly where electrodes were applied with a gel or paste containing calcium chloride.
- Heel-stick calcinosis in newborns:
- Who is affected: infants who have had repeated heel-prick blood sampling for screening tests.
- Appearance: stone-hard, chalky white nodules on the edge of the heel pad appearing 1–6 months later. Some resolve on their own as the child grows, but persistent, painful nodules need specialist treatment.
- Post-procedure calcinosis (after cosmetic procedures or local injections): develops at sites of sclerotherapy or poorly performed local corticosteroid injections, where secondary fat necrosis leads to calcium deposition.
Common Iatrogenic Causes at a Glance
| Trigger | Related Technique / Procedure | Histopathologic Features |
|---|---|---|
| Calcium gluconate extravasation | Peripheral IV infusion of calcium solution | Calcium crystals deposited around blood vessels and collagen fibers |
| Electrode paste / gel | EEG, ECG | Calcium micronodules concentrated in the superficial dermis |
| Heel stick | Capillary blood sampling for newborn screening | Localized calcified mass in the subcutaneous fat of the heel |
| Hemodialysis / renal replacement therapy | Dialysate with a high calcium concentration | Calcium deposits with fibrosis of vessel walls |
Diagnosis and Treatment at Haute-Derma
At Haute-Derma, management is tailored to the stage of the iatrogenic lesion:
- Detailed medical history: establishing when any IV therapy, diagnostic procedure or injection took place.
- High-frequency skin ultrasound (HFUS, 22–50 MHz): maps the borders of the calcium deposit, its depth (dermis or subcutis) and the extent of surrounding fibrosis.
- Systemic blood tests: calcium, phosphate, PTH and vitamin D are checked to confirm that the lesion is purely local and that there is no underlying metabolic disorder.
Management and Intervention
- Acute phase (newly detected extravasation):
- Stop the calcium-containing IV infusion immediately.
- Infiltrate the area with hyaluronidase or 10% sodium thiosulfate (STS) to help dissolve the trapped calcium and limit fibrosis.
- Chronic phase (hardened, localized calcium deposit):
- Topical sodium thiosulfate (STS) application or soaks: 10–25% STS applied as a local compress chelates calcium ions, forming soluble calcium thiosulfate.
- UltraPulse CO2 laser micro-ablation: for superficial subepidermal nodules or electrode-related lesions. The laser creates a fine channel that gently vaporizes the fibrous capsule and removes the calcium core.
- Minimal excision: for painful heel deposits or large, deep subcutaneous calcified plaques, fully relieving pressure on sensory nerves.
Microsurgical and Laser Treatment at Haute-Derma
Depending on how far the lesion has progressed, Haute-Derma offers the following interventions:
Acute Management (Newly Detected Extravasation)
- Technique: the IV line is stopped immediately and the area is infiltrated with hyaluronidase or 10% sodium thiosulfate (STS).
- Effect: speeds up the dissolution and dispersal of trapped calcium ions, preventing fibrosis and extensive skin necrosis.
Chronic Management (Hardened Calcium Deposits)
- Topical Sodium Thiosulfate (STS) Compresses: a 10–25% STS solution is applied under compression to the affected area. STS acts as a chelating agent, binding calcium ions into water-soluble calcium thiosulfate that is easily cleared.
- UltraPulse CO2 Laser Micro-ablation: for small superficial subepidermal nodules or electrode-related lesions. The laser opens tiny channels to vaporize the surrounding fibrous capsule and gently remove the calcium core without harming healthy tissue.
- Minimal Excision: for heel calcifications or large subcutaneous plaques that are painful and compress nerves. The doctor removes the entire calcium core through a very small incision and closes it with fine absorbable sutures.
